Skip to main content

Table 3 Medical treatment at hospital discharge in 1062 patients with acute coronary syndrome

From: Long-term clinical outcome in patients with acute coronary syndrome and dysglycaemia

 

NGT

IFG/IGT

DiabetesA

DiabetesB

P

No.

295

299

156

312

 

Female/male (n)

76/219

77/222

40/116

88/224

NS

Treatment at discharge (%)

 Aspirin

97.8l

97.5l

96.7l

89.4c,f,i

<0.001

 Clopidogrel

80.6l

81.1l

80.0l

66.7c,f,i

<0.001

 Beta-blockers

94.7l

96.1l

97.3l

95.0c,f,i

NS

 Calcium antagonists

9.2l

14.6l

9.3l

24.6c,f,i

<0.001

 ACE inhibitors

51.2f,i,l

62.6c

70.7c

63.8c

<0.001

 Angiotensin II receptor blockers

7.8f,i,l

12.5c,l

12.0c,l

21.9c,f,i

<0.001

 Diuretics

8.9f,i,l

16.8l

16.7l

42.5c,f,i

<0.001

 Statins

94.7l

92.9l

95.3l

88.0c,f,i

<0.01

 Oral antidiabetic medication

0i,l

0i,l

7.3c,f,l

56.1c,f,i

<0.001

 Insulin

0l

0l

0l

52.7c,f,i

<0.001

 Oral antidiabetic medication and Insulin

0l

0l

0l

26.3c,f,i

<0.001

  1. vs NGT, ap < 0.05, p < 0.01, c p < 0.001; vs IFG/IGT, p < 0.05, p < 0.01, p < 0.001; vs Diabetes OGTT, g p < 0.05, h p < 0.01, i p < 0.001; vs known diabetes, p < 0.05, k p < 0.01, l p < 0.001
  2. APatients with diabetes discovered by OGTT
  3. BPatients with known diabetes at admission